Angion Biomedica Corp

NASDAQ:ANGN   3:59:46 PM EDT
13.07
-0.57 (-4.18%)
Other Pre-Announcement

Angion Biomedica Expects Current Cash Resources, With Potential Milestones Payable Under Agreement With Vifor To Fund Planned Operations Into 2022

Published: 05/17/2021 10:55 GMT
Angion Biomedica Corp (ANGN) - Angion Biomedica - Expects Current Cash Resources, With Potential Milestones Payable Under Agreement With Vifor to Fund Planned Operations Into 2022.
Angion Biomedica Corp - Qtrly Net Loss per Common Share, Basic and Diluted $1.56.
Angion Biomedica - Expects Topline Phase 2 Data for Ang-3777 in Acute Lung Injury Associated With Covid 19 Related Pneumonia in H1 2021.